Waltham, MA, United States of America

Timothy Briggs

This inventor holds 2 USPTO granted patents. Top assignee: Sail Biomedicines. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy Briggs. Retrieved from https://idiyas.com/inventor/timothy-briggs-uhwfklc7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Timothy Briggs

Introduction

Timothy Briggs is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of medical science, particularly in the treatment of Parkinson's disease. His innovative work has led to the development of a patent that addresses critical health challenges.

Latest Patents

Timothy Briggs holds a patent for "Decarboxylase inhibitors for treating Parkinson's disease." This patent provides inhibitors of pathogenic, bacterial metabolite production and conjugates of the inhibitors. Additionally, it includes pharmaceutical compositions containing the inhibitors or conjugates and methods of using the same. This invention represents a promising advancement in the treatment options available for Parkinson's disease.

Career Highlights

Briggs is currently associated with Sail Biomedicines, where he continues to work on groundbreaking research and development. His role at the company allows him to collaborate with other talented professionals in the field, enhancing the potential impact of his inventions.

Collaborations

Some of Timothy Briggs' coworkers include Devin Forest Reed Doud and Steven Taylor. Their collaboration fosters a dynamic environment for innovation and research, contributing to the advancement of medical treatments.

Conclusion

Timothy Briggs is a notable inventor whose work in developing decarboxylase inhibitors has the potential to transform the treatment landscape for Parkinson's disease. His contributions to Sail Biomedicines and collaboration with other professionals highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…